title: Cell culture process operations for recombinant protein production.
abstract: The market for protein therapeutics has grown significantly over the past two decades and the pace of development continues to increase. It is a challenge to the industry to maintain the desired quality attributes while accelerating delivery to patients, reducing the cost of goods, and providing production flexibility. Efficient manufacturing scale production of protein therapeutics is required to continue to meet the needs of the patients and stockholders. This chapter describes batch, fed-batch, and perfusion processes and their utilization in the production of monoclonal antibodies and other therapeutic proteins. In addition, we have provided detailed discussions of the ongoing challenges of lactate metabolism and the future prospects of process monitoring and control.
authors.affiliation: Bristol-Myers Squibb, Manufacturing Sciences and Technology, 38 Jackson Road, Devens, MA, 01434, USA, susan.abuabsi@bms.com.
authors.forename: Susan
authors.initials: S
authors.lastname: Abu-Absi
authors.forename: Sen
authors.initials: S
authors.lastname: Xu
authors.forename: Hugh
authors.initials: H
authors.lastname: Graham
authors.forename: Nimish
authors.initials: N
authors.lastname: Dalal
authors.forename: Marcus
authors.initials: M
authors.lastname: Boyer
authors.forename: Kedar
authors.initials: K
authors.lastname: Dave
mesh_terms: D000818:Animals; D061249:Batch Cell Culture Techniques / Q000379:methods*; D019149:Bioreactors; D015195:Drug Design; D006801:Humans; D015202:Protein Engineering / Q000379:methods*; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000627:therapeutic use*; D012371:Robotics / Q000379:methods
chemical_list: D011994:Recombinant Proteins